Publications by authors named "C A Hoeger"
Background: Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging enables imaging of scar/fibrosis and is a cornerstone of most CMR imaging protocols. CMR imaging can benefit from image acceleration; however, image acceleration in LGE remains challenging due to its limited signal-to-noise ratio. In this study, we sought to evaluate a rapid 2D LGE imaging protocol using a generative artificial intelligence (AI) algorithm with inline reconstruction.
View Article and Find Full Text PDFAnthracycline chemotherapy is associated with cardiotoxicity, predominantly manifesting as left ventricular systolic dysfunction within the first year of treatment. Early detection is possible through biomarkers and cardiovascular imaging before clinical symptoms develop. Comprehensive cardiovascular risk assessment is essential for all patients prior to anthracycline therapy to stratify their risk of cardiotoxicity.
View Article and Find Full Text PDFArticle Synopsis
- Hematopoietic stem cell transplantation (HSCT) can lead to various cardiovascular complications, and this study aimed to assess the occurrence and risk factors of these events in patients post-transplant.
- Researchers analyzed data from 3,354 adult patients who underwent HSCT from 2008 to 2019, tracking cardiovascular outcomes within 100 days and beyond, with a focus on incidents like heart failure and atrial fibrillation.
- Results showed a low short-term incidence of cardiovascular events (4.1%) but a higher long-term incidence (13.9%), particularly among allogeneic transplant recipients and individuals with pre-existing heart conditions.
Article Synopsis
- A study aimed to create a risk score for assessing cardiovascular risks in patients undergoing hematopoietic stem cell transplantation (HSCT) due to limited existing guidelines.
- Using data from the CARE-BMT study, researchers analyzed various predictive factors related to cardiovascular events in over 2,400 HSCT patients, leading to the development of a point-based risk score.
- This score categorizes patients into low, intermediate, and high-risk groups for cardiovascular issues post-transplant, potentially aiding in specialist referrals and long-term monitoring of high-risk individuals.
Cardiovascular effects of cancer therapies are of concern. Prediction, diagnosis, and management of cardiotoxicity is a challenge. Cardiovascular biomarkers are being studied in relationship to cancer therapy, showing promise in detection and prevention of cardiotoxicity.
View Article and Find Full Text PDF